---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-070568"
form_type: "8-K"
ticker: "ACET"
cik: "0001720580"
company_name: "Adicet Bio, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:37:31.605300+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Adicet Bio stockholders approve doubling authorized shares to 300M and 5M share plan increase

## Summary
- Authorized common shares increased from 150M to 300M via charter amendment; filed June 6.
- 2018 Stock Plan increased by 5M shares to 16.6M total; approved with 28.9M votes for.
- Contingent option grants become effective: CEO Chen Schor receives 1.77M options; CFO Nick Harvey 375k; total 3.3M across management.
- Charter amendment adopted to limit officer liability as permitted by Delaware law.

## SEC filing metadata
- accession: 0000950170-24-070568
- form_type: 8-K
- ticker: ACET
- cik: 0001720580
- company_name: Adicet Bio, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720580/000095017024070568/0000950170-24-070568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720580/000095017024070568/acet-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-070568
- JSON: https://secwatch.observer/filing/0000950170-24-070568.json
- Plain text: https://secwatch.observer/filing/0000950170-24-070568.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.